Micronics, a privately held microfluidics company in Redmond, Wash., has been developing a microfluidics microcytometry chip in collaboration with Honeywell that could be used as a mobile diagnostic device on a field soldier s wrist.
As concerns mount about preparedness for bioterrorism in the US, one microarray lab has already begun applying biochip technology to develop gene-based detection platforms for exposure to biological warfare agents.
The air freight slowdown and economic fluctuations in the wake of the Sept. 11 terrorist attacks in the US have not interrupted the growth trajectory of the biochip and microarray sector in any significant way, companies have told BioArray News.
Agilent and Incyte have expanded an existing licensing agreement to enable Agilent to offer a more comprehensive range of catalog and custom microarrays using Incyte s gene patent portfolio and its LifeSeq genomic database. Using LifeSeq, Agilent said it would develop highly specific cDNA- and oligonucleotide-based microarrays.